Yesterday, Jan. 4, 2016, 49 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $184.24 to $5,809,890.90.

Highlighted Stocks Traded by Insiders:

Conmed (CNMD) - FREE Research Report

Farkas Charles, who is Director at Conmed, bought 332 shares at $42.18 on Jan. 4, 2016. Following this transaction, the Director owned 4,064 shares meaning that the stake was boosted by 8.9% with the 332-share transaction.

The shares most recently traded at $44.01, up $1.83, or 4.15% since the insider transaction. Historical insider transactions for Conmed go as follows:

  • 4-Week # shares bought: 1,500
  • 4-Week # shares sold: 2,500
  • 12-Week # shares bought: 1,500
  • 12-Week # shares sold: 2,500
  • 24-Week # shares bought: 5,792
  • 24-Week # shares sold: 2,500

The average volume for Conmed has been 181,500 shares per day over the past 30 days. Conmed has a market cap of $1.2 billion and is part of the health care sector and health services industry. Shares are down 1.33% year-to-date as of the close of trading on Wednesday.

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures and monitoring in the United States, Canada, the United Kingdom, Japan, Australia, and internationally. The stock currently has a dividend yield of 1.8%. The company has a P/E ratio of 36.5. Currently, there are 3 analysts who rate Conmed a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CNMD - FREE

TheStreet Quant Ratings rates Conmed as a hold. The company's strengths can be seen in multiple areas, such as its increase in net income, largely solid financial position with reasonable debt levels by most measures and reasonable valuation levels. However, as a counter to these strengths, we find that we feel that the company's cash flow from its operations has been weak overall. Get the full Conmed Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Air Lease (AL) - FREE Research Report

Baer Marc H, who is Evp at Air Lease, sold 1,500 shares at $32.62 on Jan. 4, 2016. Following this transaction, the Evp owned 115,811 shares meaning that the stake was reduced by 1.28% with the 1,500-share transaction.

The shares most recently traded at $33.48, up $0.86, or 2.57% since the insider transaction. Historical insider transactions for Air Lease go as follows:

  • 4-Week # shares bought: 5,000
  • 4-Week # shares sold: 1,500
  • 12-Week # shares bought: 5,000
  • 12-Week # shares sold: 3,000
  • 24-Week # shares bought: 5,000
  • 24-Week # shares sold: 7,500

The average volume for Air Lease has been 943,700 shares per day over the past 30 days. Air Lease has a market cap of $3.4 billion and is part of the services sector and diversified services industry. Shares are down 2.51% year-to-date as of the close of trading on Wednesday.

Air Lease Corporation engages in the purchase and leasing of commercial jet transport aircraft to airlines worldwide. The company also sells aircraft from its operating lease portfolio to third parties, including other leasing companies, financial services companies, and airlines. The stock currently has a dividend yield of 0.59%. The company has a P/E ratio of 15.0. Currently, there are 9 analysts who rate Air Lease a buy, 1 analyst rates it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AL - FREE

TheStreet Quant Ratings rates Air Lease as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, expanding profit margins, growth in earnings per share and increase in net income. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Air Lease Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Century Bancorp (CNBKA) - FREE Research Report

Filler James J, who is 10% Owner at Century Bancorp, bought 960 shares at $43.00 on Jan. 4, 2016. Following this transaction, the 10% Owner owned 487,642 shares meaning that the stake was boosted by 0.2% with the 960-share transaction.

The shares most recently traded at $44.25, up $1.25, or 2.82% since the insider transaction. Historical insider transactions for Century Bancorp go as follows:

  • 4-Week # shares bought: 4,526
  • 12-Week # shares bought: 19,425
  • 24-Week # shares bought: 493,403

The average volume for Century Bancorp has been 3,100 shares per day over the past 30 days. Century Bancorp has a market cap of $159.0 million and is part of the financial sector and banking industry. Shares are up 8.96% year-to-date as of the close of trading on Wednesday.

Century Bancorp, Inc. operates as a bank holding company for Century Bank and Trust Company that provides banking products and services in Massachusetts. The stock currently has a dividend yield of 1.09%. The company has a P/E ratio of 10.8.

Exclusive Offer: Get the latest Stock Analysis on CNBKA - FREE

TheStreet Quant Ratings rates Century Bancorp as a hold. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and growth in earnings per share. However, as a counter to these strengths, we find that the company's return on equity has been disappointing. Get the full Century Bancorp Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.